Position in PBYI
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,565,541
+$321,150 QoQ
Shares Held
316,343
-9.9% QoQ
Ownership
0.613%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#26
of 160 holders
Holding Since
Mar 2020
20 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PBYI Over Time
Shares Held
Position Value (USD)
Derivatives in PBYI
reported options exposure · as of Dec 31, 2020CallValue
$0
CallShares
0
PutValue
$290,358
PutShares
28,300
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026D. E. Shaw & Co., Inc. holds $5,139,216,221 across 216 Biotechnology names. PBYI ranks #124 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
5,877,959 | $626,707,987 | |
| 2 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,104,109 | $332,369,932 | |
| 3 | EXEL |
Exelixis, Inc.
|
5,551,747 | $302,070,554 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
3,633,007 | $270,586,360 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
3,400,808 | $186,840,390 | |
| 6 | HALO |
Halozyme Therapeutics, Inc.
|
2,006,479 | $157,047,110 | |
| 7 | AXSM |
Axsome Therapeutics, Inc.
|
604,753 | $148,025,391 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
1,548,919 | $126,345,322 |
All Filings in PBYI
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,565,541 | 316,343 | Shares | Defined | 2026-08-14 | |
| 2026-03-31 | $2,244,391 | 351,235 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $2,250,861 | 378,296 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $2,647,555 | 498,598 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $2,197,875 | 640,780 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $1,692,128 | 571,665 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $678,954 | 222,608 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $146,339 | 57,388 | Shares | Defined | 2024-11-14 | |
| 2022-12-31 | $559,138 | 132,184 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,276,349 | 538,544 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $2,736,204 | 960,072 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,897,230 | 1,005,983 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $2,237,324 | 735,962 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $352,406 | 50,272 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $1,023,625 | 111,506 | Shares | Defined | 2021-08-16 | |
| 2021-03-31 | $779,505 | 80,196 | Shares | Defined | 2021-05-17 | |
| 2020-12-31 | $357,140 | 34,809 | Shares | Defined | 2021-02-16 | |
| 2020-12-31 | $290,358 | 28,300 | Put | Defined | 2021-02-16 | |
| 2020-09-30 | $285,547 | 28,300 | Put | Defined | 2020-11-16 | |
| 2020-09-30 | $304,888 | 30,217 | Shares | Defined | 2020-11-16 | |
| 2020-06-30 | $1,981,814 | 190,011 | Shares | Defined | 2020-08-14 | |
| 2020-06-30 | $295,169 | 28,300 | Put | Defined | 2020-08-14 | |
| 2020-03-31 | $1,317,424 | 156,093 | Shares | Defined | 2020-05-15 | |
| 2020-03-31 | $238,852 | 28,300 | Put | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||